Welcome to the February edition of the HealthLink Dimensions' Monthly Insights!
This month's issue includes the first episode of the NEW HealthLink Signals executive video podcast, new insights and resources, a recap of our latest industry events, and a message from the CEO about trust.
Watch Episode One of HealthLink Signals
Delivering What Clinicians Actually Need:
Trust AI, and Reinvention
Featuring Matt Holland, Chief Operating Officer of Healio
In the inaugural episode of HealthLink Signals, Matt Holland reflects on 25 years in medical publishing and the responsibility that comes with serving clinicians at scale. From the shift toward personalization and microlearning to the rise of AI-powered tools, Holland shares how physician expectations are changing and what it means to meet them responsibly.
Network Directory Validation in 2026: What Payers Must Do Next
In 2026, provider network directory accuracy is no longer a “compliance checkbox.” It has become a defining expectation across commercial, marketplace, and government-sponsored healthcare.
Do You Have 5 Minutes? With HealthLink CMO Nathan Lenyszyn
From the rising “clean data” premium to emerging 2026 trends, Nathan shares what is coming into focus for marketers, the roadblocks he anticipates, and how organizations can navigate them while maintaining precision and performance.
Thanks to all we met at ACEHP, Brand Insider Summit, and ViVE!
Our HealthLink team had a great time connecting with everyone at the ACEHP Annual Conference, Brand Insider Summit, and ViVE 2026 in February. We look forward to continuing our involvement and furthering connects at March conferences!
See You Next Month!
Message from the CEO: Foundational Trust
Last month, I spoke about the rapid scaling of AI and the shifting regulatory landscape. I was fortunate to experience the palpable energy and the underlying anxiety among C-suite executives, innovators, and entrepreneurs while at JPM Health Conference in San Fransisco. From these conversations, it is clear that AI tools are being deployed across the healthcare sector with a primary goal: relieving the administrative burden on clinicians to reclaim time for patient care. We are also seeing a surge in high-level collaboration between tech and pharma, exemplified by the AI drug discovery lab recently launched through the partnership between Nvidia and Eli Lilly.
However, this momentum in innovation is only as strong as the foundation it sits upon. As we move deeper into 2026, a defining theme is emerging: Engagement and Adoption cannot exist without Trust.
In our first episode of HealthLink Signals, Matt Holland from Healio noted that "one-size-fits-all education no longer works." I couldn’t agree more. But for personalization to be effective, the underlying data must be beyond reproach. At HealthLink, this is exactly why we champion our "Continuous Verification" model.
Best Wishes,
Amar Duggasani
President & CEO
HealthLink Dimensions
HealthLink Dimensions, 1001 Summit Blvd NE, Suite 1125, Atlanta, GA 30319
